Abstract
<p indent="0mm">Cataract is the leading cause of vision impairment worldwide. As the population ages, the prevalence of cataract will increase rapidly, which has caused a substantial social and economic burden. Although cataract surgery is effective, it still suffers from complications and high costs and could not meet the increasing surgery demand. Therefore, pharmacological treatment for cataracts is cheaper and more readily available for patients. Therefore, research on the pathogenesis of cataract and exploring potential therapeutic drugs for cataract have always been a research hotspot for years. Based on our team’s current work, this article summarizes the pathogenesis and pharmacotherapy strategies of cataract from the pathogenesis of cataract, the cataract disease models, and the development of anti-cataract drugs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
